Leveraged Commentary and Data’s (LCD) credit data, news, and research are now on PitchBook.
Learn more »
Latest Deal Type
Latest Deal Amount
Arexis General Information
Operator of a pharmaceutical company intended to develop metabolic and inflammatory disease therapeutics. The company's research is biology-driven with proprietary technology and a focus on the development of pharmaceuticals for the treatment of lipid malabsorption, diabetes, atopic dermatitis (inflammatory skin disease) and rheumatoid arthritis, enabling doctors with novel therapies to easily treat patients.